Illumina, Inc (NASDAQ:ILMN) Accelerates Multiomics Expansion After SomaLogic Close
![]() |
Momentum in corporate strategy and product-level reimbursement shifted the narrative toward multiomics expansion; near-term price action must reconcile bullish momentum with constrained trend strength. |










